← Back to Search

Polyphenol

Hydroxytyrosol for Breast Cancer

Phase 2 & 3
Waitlist Available
Led By Jenny Chang, MD
Research Sponsored by The Methodist Hospital Research Institute
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline and 12 months
Awards & highlights

Study Summary

This trial is testing whether a component of olive oil can help reduce the risk of breast cancer in high-risk women.

Eligible Conditions
  • Breast Cancer

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline and 12 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline and 12 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in Maximum Volumetric Breast Density Percentage
Secondary outcome measures
Number of Participants With Adverse Events
Other outcome measures
Expression of Ki67 in Tumor Tissue
MRI Breast Density

Side effects data

From 2021 Phase 2 & 3 trial • 51 Patients • NCT02068092
4%
Fatigue
100%
80%
60%
40%
20%
0%
Study treatment Arm
Hydroxytyrosol

Trial Design

1Treatment groups
Experimental Treatment
Group I: HydroxytyrosolExperimental Treatment1 Intervention
Hydroxytyrosol 25 mg orally once daily for 1 year.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Hydroxytyrosol
Not yet FDA approved

Find a Location

Who is running the clinical trial?

The Methodist Hospital Research InstituteLead Sponsor
271 Previous Clinical Trials
80,324 Total Patients Enrolled
12 Trials studying Breast Cancer
300 Patients Enrolled for Breast Cancer
Jenny Chang, MDPrincipal InvestigatorThe Methodist Hospital Research Institute
5 Previous Clinical Trials
164 Total Patients Enrolled
4 Trials studying Breast Cancer
107 Patients Enrolled for Breast Cancer

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
Olive Oil for High Risk Breast Cancer Prevention in Women
Jenny C. Chang, MD 2013. "Olive Oil for High Risk Breast Cancer Prevention in Women". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT02068092.
~4 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top